GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kimia Biosciences Ltd (BOM:530313) » Definitions » Net Margin %

Kimia Biosciences (BOM:530313) Net Margin % : 0.00% (As of . 20)


View and export this data going back to 2017. Start your Free Trial

What is Kimia Biosciences Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Kimia Biosciences's Net Income for the six months ended in . 20 was ₹0.00 Mil. Kimia Biosciences's Revenue for the six months ended in . 20 was ₹0.00 Mil. Therefore, Kimia Biosciences's net margin for the quarter that ended in . 20 was 0.00%.

The historical rank and industry rank for Kimia Biosciences's Net Margin % or its related term are showing as below:


BOM:530313's Net Margin % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 3.19
* Ranked among companies with meaningful Net Margin % only.

Kimia Biosciences Net Margin % Historical Data

The historical data trend for Kimia Biosciences's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kimia Biosciences Net Margin % Chart

Kimia Biosciences Annual Data
Trend
Net Margin %

Kimia Biosciences Semi-Annual Data
Net Margin %

Competitive Comparison of Kimia Biosciences's Net Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Kimia Biosciences's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kimia Biosciences's Net Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kimia Biosciences's Net Margin % distribution charts can be found below:

* The bar in red indicates where Kimia Biosciences's Net Margin % falls into.



Kimia Biosciences Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Kimia Biosciences's Net Margin for the fiscal year that ended in . 20 is calculated as

Net Margin=Net Income (A: . 20 )/Revenue (A: . 20 )
=/
= %

Kimia Biosciences's Net Margin for the quarter that ended in . 20 is calculated as

Net Margin=Net Income (Q: . 20 )/Revenue (Q: . 20 )
=/
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Kimia Biosciences  (BOM:530313) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Kimia Biosciences Net Margin % Related Terms

Thank you for viewing the detailed overview of Kimia Biosciences's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Kimia Biosciences (BOM:530313) Business Description

Traded in Other Exchanges
N/A
Address
Netaji Subhash Place, 974, 9th Floor, Aggarwal Millenium Tower-II, Pitampura, New Delhi, IND, 110 034
Kimia Biosciences Ltd is a company engaged in the manufacturing of bulk drugs. Some of the company's products include Azelnidipine, Deflazacort, Oxaceprol, Seratodast, and Tretinoin among others. Its only operating segment being Pharmaceuticals.

Kimia Biosciences (BOM:530313) Headlines

No Headlines